Releases

TitleDateSizeView
Trading HaltApril 29, 2022229 KB Download
Appendix 4C Quarterly Cash Flow ReportApril 29, 2022462 KB Download
Revised date for release of Quarterly ResultsApril 27, 2022220 KB Download
Quarterly Results and Investor Conference Call NotificationApril 21, 2022221 KB Download
Appendix 4E (Rule 4.3A): Preliminary Final Report for the Year Ended 31 December 2021February 28, 2022210 KB Download
Osprey Medical Financial Results for FY2021February 28, 2022505 KB Download
Annual Meeting of StockholdersFebruary 1, 2022207 KB Download
Osprey demonstrates resilience through OUS salesJanuary 31, 2022506 KB Download
Quarterly Results and Investor Conference Call NotificationJanuary 24, 2022222 KB Download
Osprey Medical to Present at Upcoming Investor ConferencesNovember 25, 20211 MB Download
DyeVert™ is highlighted by leading experts for reduction of Acute Kidney InjuryOctober 28, 2021265 KB Download
Strategic distribution agreements lead to record sales in EuropeOctober 20, 2021472 KB Download
Quarterly Results and Investor Conference Call NotificationOctober 13, 2021222 KB Download
Osprey Medical’s DyeVert™ Technology Featured at Prominent Italian Society of Interventional Cardiology Scientific MeetingOctober 11, 2021218 KB Download
Reverse Stock Split and Dispatch of Holding StatementsSeptember 23, 2021171 KB Download
GE Healthcare ramps up promotion of Osprey Medical’s DyeVert System across EuropeSeptember 23, 202116 MB Download
ASX ANNOUNCEMENT – Results of Special Meeting of StockholdersSeptember 3, 2021229 KB Download
Consolidation/Split – OSPAugust 20, 202125 KB Download
Notice of Special Meeting of StockholdersAugust 20, 2021573 KB Download
Global expansion strategy progress strengthens revenues in the first half of 2021August 17, 2021299 KB Download
Half-Year Information for Six Months Ended 30 June 2021August 17, 2021467 KB Download
Martin Emerson appointed to Osprey Medical’s Board of DirectorsAugust 12, 2021178 KB Download
Osprey continues to deliver positive results through strategic distribution agreementsJuly 29, 2021537 KB Download
Quarterly Results and Investor Conference Call NotificationJuly 22, 2021225 KB Download
Osprey expands into Canada with MDL approval and exclusive GE Healthcare distribution agreementJuly 20, 2021262 KB Download
Steven Brandt appointed to Osprey Medical’s Board of DirectorsJuly 1, 2021177 KB Download
Results of 2021 Annual Meeting of StockholdersMay 11, 2021261 KB Download
Strong quarter for Osprey with continued growth in units and revenueApril 22, 2021619 KB Download
Notice of Annual Meeting of StockholdersApril 20, 2021618 KB Download
Quarterly Results and Investor Conference Call NotificationApril 16, 2021217 KB Download
CEO Business Update Investor PresentationApril 16, 202118 MB Download
Appendix 4G Key to Disclosures Corporate Governance Council Principles and RecommendationsMarch 30, 2021252 KB Download
Osprey expands US sales coverageMarch 18, 2021360 KB Download
Osprey presents at ASX Small & Mid-Cap Conference and Oppenheimer Healthcare ConferenceMarch 10, 202118 MB Download
Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)March 3, 2021181 KB Download
Osprey expands US sales coverage with new sales agency agreementsMarch 2, 2021432 KB Download
Osprey Medical Financial Results for FY2020February 26, 2021250 KB Download
Funding Update – Exercise of Options and PPP LoanFebruary 23, 2021181 KB Download
Notice of Final Exercise of Options and Underwriting ArrangementsFebruary 12, 2021474 KB Download
4C and Business UpdateJanuary 28, 2021537 KB Download
Quarterly Results and Investor Conference Call NotificationJanuary 22, 2021215 KB Download
Osprey Investor PresentationJanuary 12, 202113 MB Download
Osprey Investor PresentationDecember 3, 20202 MB Download
Osprey signs strategic sales agency agreement for new US regionNovember 26, 2020288 KB Download
Strong quarter for Osprey with milestone distribution agreements signedOctober 29, 2020529 KB Download
Exercise of OptionsOctober 21, 2020176 KB Download
Quarterly Results and Investor Conference Call NotificationOctober 21, 2020213 KB Download
Osprey receives Supplier Horizon Award from Premier IncSeptember 29, 2020239 KB Download
Regional Health Care Group to distribute Osprey Medical kidney protection technology across Australia and New ZealandSeptember 24, 2020261 KB Download
Osprey to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceSeptember 15, 2020211 KB Download
Notice of Exercise of OptionsSeptember 14, 2020177 KB Download
Positive outlook following adjustments to COVID-19August 25, 2020314 KB Download
Appendix 4D Half-Year Report for the Six Months Ended 30 June 2020August 25, 2020472 KB Download
Resignation of Andy Jane from the Board of DirectorsAugust 18, 2020177 KB Download
CE Marking received for core European product, DyeVert Power XTAugust 13, 2020312 KB Download
GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)July 30, 2020257 KB Download
Positive traction in the Quarter that was defined by COVID-19July 28, 2020536 KB Download
Shortfall Placement Update and Quarterly Results Release NotificationJuly 15, 2020227 KB Download
Response to ASX Price QueryJuly 3, 2020303 KB Download
Results of 2020 Annual Meeting of StockholdersJune 19, 2020227 KB Download
2020 Annual Meeting of Stockholders – Chairman’s Address and Presentation by President and CEOJune 19, 202011 MB Download
Issue of Securities under Shortfall PlacementJune 12, 2020176 KB Download
Appendix 2A: Application for quotation of +securitiesJune 12, 2020279 KB Download
Appendix 3G: Notification of issue, conversion or payment up of equity +securitiesJune 12, 2020381 KB Download
Notice of Exercise of OptionsJune 10, 2020368 KB Download
Osprey Medical successfully raises an additional $2.6m under Shortfall PlacementJune 9, 2020179 KB Download
Trading HaltJune 4, 2020365 KB Download
Notice of Annual Meeting of StockholdersMay 29, 20203 MB Download
ASX AnnouncementMay 29, 2020164 KB Download
DyeVert™ featured at the SCAI 2020 Scientific Session: Procedure-Based Strategies to reduce Contrast-Induced Acute Kidney InjuryMay 28, 2020223 KB Download
Allotment of Securities under Entitlement OfferMay 1, 2020118 KB Download
Appendix 2A: Application for quotation of +securitiesMay 1, 2020156 KB Download
Appendix 3G: Notification of issue, conversion or payment up of equity +securitiesMay 1, 2020140 KB Download
Quarterly Results and COVID-19 UpdateApril 30, 2020253 KB Download
Completion of Entitlement OfferApril 29, 2020182 KB Download
Osprey Medical Secures US Government COVID-19 Relief LoanApril 29, 2020175 KB Download
Quarterly Results and Investor Conference Call NotificationApril 17, 2020215 KB Download
ASX ANNOUNCEMENT: 2020 Annual Meeting of StockholdersApril 16, 2020235 KB Download
Dispatch of Prospectus, Entitlement and Acceptance FormsApril 15, 2020785 KB Download
Rights Commence TradingApril 7, 2020184 KB Download
ASX ANNOUNCEMENT: Entitlement Offer – Notification to Ineligible CDI Holders and OptionholdersApril 6, 2020196 KB Download
Amended and Restated Certificate of IncorporationApril 3, 2020634 KB Download
Osprey Medical ProspectusApril 3, 2020489 KB Download
Proposed Issues of SecuritiesApril 3, 202042 KB Download
Osprey Medical Announces Capital Raising and Trading UpdateApril 3, 2020129 KB Download
Trading HaltApril 1, 2020354 KB Download
Appendix 4G Corporate Governance CouncilMarch 26, 2020204 KB Download
ASX ANNOUNCEMENT – 2020 Annual Meeting of StockholdersMarch 26, 2020196 KB Download
4E Cover MemoFebruary 25, 2020103 KB Download
Osprey Medical Financial Results for FY2019February 25, 2020222 KB Download
Appendix 4E (Rule 4.3A): Preliminary Final Report for the Year Ended 31 December 2019February 24, 2020550 KB Download
UK NICE Issues Positive MedTech Innovation Briefing on DyeVert™February 10, 2020229 KB Download
ASX ANNOUNCEMENT – 2020 Annual Meeting of StockholdersFebruary 6, 2020197 KB Download
Appendix 4C: Quarterly report for entities subject to listing rule 7.8BFebruary 5, 202069 KB Download
36% Increase in DyeVert Unit SalesJanuary 31, 2020499 KB Download
Amendment to Quarterly Results and Investor Conference Call NotificationJanuary 21, 2020220 KB Download
Quarterly Results and Investor Conference Call NotificationJanuary 10, 2020215 KB Download